DEBORAH HEART AND LUNG CENTER — History
CCN 310031 | 3-year financial timeline | COVID resilience: 73/100
🛡️ Public data only — no PHI permitted on this instance.
$212M
Latest Revenue (FY2022)
+8.7%
Revenue CAGR (3yr)
-5.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $179M | $203M | $212M | +4.2% | +8.7% |
| Operating Expenses | $202M | $215M | $224M | +4.0% | +5.2% |
| Operating Margin | -12.6% | -5.7% | -5.5% | +3.4% | +0.0% |
| Net Income | $-23M | $-12M | $-12M | -0.7% | +0.0% |
| Licensed Beds | 86 | 86 | 85 | -1.2% | -0.6% |
| Total Patient Days | 20,352 | 21,081 | 20,386 | -3.3% | +0.1% |
| Medicare Day % | 43% | 39% | 38% | -1.9% | -4.9% |
| Medicaid Day % | 1% | 2% | 1% | -36.8% | -6.6% |
COVID Impact & Recovery
Resilience Score: 73/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +18.1% ($179M → $212M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.7%
This Hospital
+7.6%
State Avg
Latest Margin
-5.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $228M | -1.9% |
| FY2024 (proj) | $244M | 1.6% |
| FY2025 (proj) | $261M | 5.2% |